Thomas Stratford
Director/Board Member at Kyowa Kirin International Plc
Thomas Stratford active positions
Companies | Position | Start | End |
---|---|---|---|
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Director/Board Member | - | - |
Chief Executive Officer | 2011-09-06 | - |
Career history of Thomas Stratford
Former positions of Thomas Stratford
Companies | Position | Start | End |
---|---|---|---|
GSK PLC | Corporate Officer/Principal | - | - |
Training of Thomas Stratford
King's College London | Doctorate Degree |
Statistics
International
United Kingdom | 4 |
Operational
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
GSK PLC | Health Technology |
Private companies | 1 |
---|---|
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Thomas Stratford
- Experience